TFDP1_HUMAN - dbPTM
TFDP1_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID TFDP1_HUMAN
UniProt AC Q14186
Protein Name Transcription factor Dp-1
Gene Name TFDP1
Organism Homo sapiens (Human).
Sequence Length 410
Subcellular Localization Nucleus . Cytoplasm . Shuttles between the cytoplasm and nucleus and translocates into the nuclear compartment upon heterodimerization with E2F1.
Protein Description Can stimulate E2F-dependent transcription. Binds DNA cooperatively with E2F family members through the E2 recognition site, 5'-TTTC[CG]CGC-3', found in the promoter region of a number of genes whose products are involved in cell cycle regulation or in DNA replication. [PubMed: 8405995]
Protein Sequence MAKDAGLIEANGELKVFIDQNLSPGKGVVSLVAVHPSTVNPLGKQLLPKTFGQSNVNIAQQVVIGTPQRPAASNTLVVGSPHTPSTHFASQNQPSDSSPWSAGKRNRKGEKNGKGLRHFSMKVCEKVQRKGTTSYNEVADELVAEFSAADNHILPNESAYDQKNIRRRVYDALNVLMAMNIISKEKKEIKWIGLPTNSAQECQNLEVERQRRLERIKQKQSQLQELILQQIAFKNLVQRNRHAEQQASRPPPPNSVIHLPFIIVNTSKKTVIDCSISNDKFEYLFNFDNTFEIHDDIEVLKRMGMACGLESGSCSAEDLKMARSLVPKALEPYVTEMAQGTVGGVFITTAGSTSNGTRFSASDLTNGADGMLATSSNGSQYSGSRVETPVSYVGEDDEEDDDFNENDEDD
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
3Acetylation-----MAKDAGLIEA
-----CCCCCCEEEE
46.9819608861
3Ubiquitination-----MAKDAGLIEA
-----CCCCCCEEEE
46.9819608861
23PhosphorylationVFIDQNLSPGKGVVS
EEEECCCCCCCCEEE
38.8719664994
26UbiquitinationDQNLSPGKGVVSLVA
ECCCCCCCCEEEEEE
52.49-
27UbiquitinationQNLSPGKGVVSLVAV
CCCCCCCCEEEEEEE
30.86-
30PhosphorylationSPGKGVVSLVAVHPS
CCCCCEEEEEEECHH
18.0828464451
37PhosphorylationSLVAVHPSTVNPLGK
EEEEECHHHCCCCCH
30.0624732914
38PhosphorylationLVAVHPSTVNPLGKQ
EEEECHHHCCCCCHH
28.8424732914
44UbiquitinationSTVNPLGKQLLPKTF
HHCCCCCHHHCCCCC
45.5121890473
44AcetylationSTVNPLGKQLLPKTF
HHCCCCCHHHCCCCC
45.5126051181
44UbiquitinationSTVNPLGKQLLPKTF
HHCCCCCHHHCCCCC
45.5121890473
73PhosphorylationTPQRPAASNTLVVGS
CCCCCCCCCEEEECC
32.2420873877
75PhosphorylationQRPAASNTLVVGSPH
CCCCCCCEEEECCCC
20.5928985074
80PhosphorylationSNTLVVGSPHTPSTH
CCEEEECCCCCCCCC
11.2520873877
83PhosphorylationLVVGSPHTPSTHFAS
EEECCCCCCCCCCCC
23.4828985074
85PhosphorylationVGSPHTPSTHFASQN
ECCCCCCCCCCCCCC
35.3520873877
86PhosphorylationGSPHTPSTHFASQNQ
CCCCCCCCCCCCCCC
23.4020873877
90PhosphorylationTPSTHFASQNQPSDS
CCCCCCCCCCCCCCC
28.8120873877
91UbiquitinationPSTHFASQNQPSDSS
CCCCCCCCCCCCCCC
49.50-
92UbiquitinationSTHFASQNQPSDSSP
CCCCCCCCCCCCCCC
53.92-
95PhosphorylationFASQNQPSDSSPWSA
CCCCCCCCCCCCCCC
40.1220873877
95UbiquitinationFASQNQPSDSSPWSA
CCCCCCCCCCCCCCC
40.12-
97PhosphorylationSQNQPSDSSPWSAGK
CCCCCCCCCCCCCCC
42.5120873877
98PhosphorylationQNQPSDSSPWSAGKR
CCCCCCCCCCCCCCC
35.0620873877
101PhosphorylationPSDSSPWSAGKRNRK
CCCCCCCCCCCCCCC
30.4420873877
104AcetylationSSPWSAGKRNRKGEK
CCCCCCCCCCCCCCC
46.3326051181
120PhosphorylationGKGLRHFSMKVCEKV
CCCHHHHHHHHHHHH
16.1524719451
122UbiquitinationGLRHFSMKVCEKVQR
CHHHHHHHHHHHHHH
42.40-
122UbiquitinationGLRHFSMKVCEKVQR
CHHHHHHHHHHHHHH
42.40-
124UbiquitinationRHFSMKVCEKVQRKG
HHHHHHHHHHHHHHC
3.32-
126AcetylationFSMKVCEKVQRKGTT
HHHHHHHHHHHHCCC
38.2425953088
126UbiquitinationFSMKVCEKVQRKGTT
HHHHHHHHHHHHCCC
38.24-
130UbiquitinationVCEKVQRKGTTSYNE
HHHHHHHHCCCCHHH
43.44-
132PhosphorylationEKVQRKGTTSYNEVA
HHHHHHCCCCHHHHH
18.6626552605
133PhosphorylationKVQRKGTTSYNEVAD
HHHHHCCCCHHHHHH
37.5726552605
134PhosphorylationVQRKGTTSYNEVADE
HHHHCCCCHHHHHHH
26.2926552605
135PhosphorylationQRKGTTSYNEVADEL
HHHCCCCHHHHHHHH
17.1626552605
139UbiquitinationTTSYNEVADELVAEF
CCCHHHHHHHHHHHH
9.81-
147PhosphorylationDELVAEFSAADNHIL
HHHHHHHHHHCCCCC
17.6626552605
158PhosphorylationNHILPNESAYDQKNI
CCCCCCCCCCCCHHH
38.4826552605
160PhosphorylationILPNESAYDQKNIRR
CCCCCCCCCCHHHHH
28.3426552605
163UbiquitinationNESAYDQKNIRRRVY
CCCCCCCHHHHHHHH
51.98-
170PhosphorylationKNIRRRVYDALNVLM
HHHHHHHHHHHHHHH
8.1625072903
180N-linked_GlycosylationLNVLMAMNIISKEKK
HHHHHHHHHHCCCCC
20.92-
180N-linked_GlycosylationLNVLMAMNIISKEKK
HHHHHHHHHHCCCCC
20.9219349973
183PhosphorylationLMAMNIISKEKKEIK
HHHHHHHCCCCCCCE
30.8522817900
190UbiquitinationSKEKKEIKWIGLPTN
CCCCCCCEEEECCCC
33.57-
217UbiquitinationQRRLERIKQKQSQLQ
HHHHHHHHHHHHHHH
58.63-
219UbiquitinationRLERIKQKQSQLQEL
HHHHHHHHHHHHHHH
47.09-
221PhosphorylationERIKQKQSQLQELIL
HHHHHHHHHHHHHHH
39.63-
225UbiquitinationQKQSQLQELILQQIA
HHHHHHHHHHHHHHH
46.50-
234UbiquitinationILQQIAFKNLVQRNR
HHHHHHHHHHHHHHH
40.11-
248PhosphorylationRHAEQQASRPPPPNS
HHHHHHHCCCCCCCC
40.7728787133
301AcetylationHDDIEVLKRMGMACG
CCHHHHHHHCCCCCC
45.587683649
311PhosphorylationGMACGLESGSCSAED
CCCCCCCCCCCCHHH
40.8427732954
313PhosphorylationACGLESGSCSAEDLK
CCCCCCCCCCHHHHH
17.7427732954
315PhosphorylationGLESGSCSAEDLKMA
CCCCCCCCHHHHHHH
36.0727732954
320UbiquitinationSCSAEDLKMARSLVP
CCCHHHHHHHHHHCH
42.7221890473
360PhosphorylationTSNGTRFSASDLTNG
CCCCCEECHHHCCCC
24.4627251275
362PhosphorylationNGTRFSASDLTNGAD
CCCEECHHHCCCCCC
31.7727251275
365PhosphorylationRFSASDLTNGADGML
EECHHHCCCCCCCCE
36.2727251275
374PhosphorylationGADGMLATSSNGSQY
CCCCCEEECCCCCCC
28.8227251275
375PhosphorylationADGMLATSSNGSQYS
CCCCEEECCCCCCCC
19.0526714015
376PhosphorylationDGMLATSSNGSQYSG
CCCEEECCCCCCCCC
40.6427251275
379PhosphorylationLATSSNGSQYSGSRV
EEECCCCCCCCCCCE
30.1427251275
381PhosphorylationTSSNGSQYSGSRVET
ECCCCCCCCCCCEEC
19.3927251275
382PhosphorylationSSNGSQYSGSRVETP
CCCCCCCCCCCEECC
23.7427251275
384PhosphorylationNGSQYSGSRVETPVS
CCCCCCCCCEECCCE
27.4927251275
388PhosphorylationYSGSRVETPVSYVGE
CCCCCEECCCEECCC
26.5728985074
391PhosphorylationSRVETPVSYVGEDDE
CCEECCCEECCCCCC
18.4628985074
392PhosphorylationRVETPVSYVGEDDEE
CEECCCEECCCCCCC
16.8327732954

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
23SPhosphorylationKinaseCHEK1O14757
GPS

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of TFDP1_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of TFDP1_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
TP53B_HUMANTP53BP1physical
8896460
CDK3_HUMANCDK3physical
8846921
E2F1_HUMANE2F1physical
7892279
E2F4_HUMANE2F4physical
7892279
E2F5_HUMANE2F5physical
7892279
E2F1_HUMANE2F1physical
22629304
E2F1_HUMANE2F1physical
9199321
E2F4_HUMANE2F4physical
9199321
E2F1_HUMANE2F1physical
8816798
E2F6_HUMANE2F6physical
9704927
E2F1_HUMANE2F1physical
9704927
E2F1_HUMANE2F1physical
8832394
E2F2_HUMANE2F2physical
8832394
E2F3_HUMANE2F3physical
8832394
CBP_HUMANCREBBPphysical
8932363
E2F1_HUMANE2F1physical
15133492

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of TFDP1_HUMAN

loading...

Related Literatures of Post-Translational Modification
Acetylation
ReferencePubMed
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions.";
Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.;
Science 325:834-840(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-3, AND MASS SPECTROMETRY.
Phosphorylation
ReferencePubMed
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions.";
Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.;
Sci. Signal. 2:RA46-RA46(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-23, AND MASSSPECTROMETRY.
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach.";
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.;
Anal. Chem. 81:4493-4501(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-23, AND MASSSPECTROMETRY.
"A quantitative atlas of mitotic phosphorylation.";
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-23, AND MASSSPECTROMETRY.
"Automated phosphoproteome analysis for cultured cancer cells by two-dimensional nanoLC-MS using a calcined titania/C18 biphasic column.";
Imami K., Sugiyama N., Kyono Y., Tomita M., Ishihama Y.;
Anal. Sci. 24:161-166(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-183, AND MASSSPECTROMETRY.
"Evaluation of the low-specificity protease elastase for large-scalephosphoproteome analysis.";
Wang B., Malik R., Nigg E.A., Korner R.;
Anal. Chem. 80:9526-9533(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-23, AND MASSSPECTROMETRY.

TOP